Indole, a core nucleus for potent inhibitors of tubulin polymerization

Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicinal research reviews 2007-03, Vol.27 (2), p.209-238
Hauptverfasser: Brancale, Andrea, Silvestri, Romano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 238
container_issue 2
container_start_page 209
container_title Medicinal research reviews
container_volume 27
creator Brancale, Andrea
Silvestri, Romano
description Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi‐synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti‐tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure–activity relationship aspects of 3‐formyl‐2‐phenylindoles, heterocombretastatins, diarylindoles, 2‐aroylindoles, D‐24851, 2‐aryl‐3‐aroylindoles, 3‐aroyl‐ and 1‐aroylindoles, and arylthioindoles are discussed. © 2006 Wiley Periodicals, Inc. Med Res Rev
doi_str_mv 10.1002/med.20080
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68969234</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68969234</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4270-750eb684d7df0e20324db3ee124ded17b8bb06efe8e79498ab62276c374356f03</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EgvJY8AMoKyQkQsd2YjtL1JaXeAgBYmnFyUQY0rjYiaB8PYGW7ljNaObcuziE7FM4oQBsOMXyhAEoWCMDCpmKKWVqnQyA9rvgLN0i2yG8AlCaUr5JtqiQSmUKBuTssildjcdRHhXOY9R0RY1diCrno5lrsWkj27xYY1vnQ-SqqO1MV9umf9bzKXr7lbfWNbtko8rrgHvLuUOeziaPo4v4-u78cnR6HRcJkxDLFNAIlZSyrAAZcJaUhiPSfmJJpVHGgMAKFcosyVRuBGNSFFwmPBUV8B1yuOideffeYWj11IYC6zpv0HVBC5WJjPGkB48WYOFdCB4rPfN2mvu5pqB_pOlemv6V1rMHy9LO_FxX5NJSDwwXwIetcf5_k76ZjP8q40XChhY_V4ncv2khuUz18-25fhhf3V-BfNaSfwPSfYUJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68969234</pqid></control><display><type>article</type><title>Indole, a core nucleus for potent inhibitors of tubulin polymerization</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Brancale, Andrea ; Silvestri, Romano</creator><creatorcontrib>Brancale, Andrea ; Silvestri, Romano</creatorcontrib><description>Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi‐synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti‐tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure–activity relationship aspects of 3‐formyl‐2‐phenylindoles, heterocombretastatins, diarylindoles, 2‐aroylindoles, D‐24851, 2‐aryl‐3‐aroylindoles, 3‐aroyl‐ and 1‐aroylindoles, and arylthioindoles are discussed. © 2006 Wiley Periodicals, Inc. Med Res Rev</description><identifier>ISSN: 0198-6325</identifier><identifier>EISSN: 1098-1128</identifier><identifier>DOI: 10.1002/med.20080</identifier><identifier>PMID: 16788980</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>anti-mitotic agents ; anti-tumor drugs ; Antimitotic Agents - chemistry ; Antimitotic Agents - pharmacology ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biochemistry - methods ; Drug Design ; Humans ; indoles ; Indoles - chemistry ; Nerve Tissue Proteins - chemistry ; Nerve Tissue Proteins - pharmacology ; Structure-Activity Relationship ; tubulin ; Tubulin - drug effects ; Tubulin - metabolism ; Tubulin Modulators</subject><ispartof>Medicinal research reviews, 2007-03, Vol.27 (2), p.209-238</ispartof><rights>Copyright © 2006 Wiley Periodicals, Inc.</rights><rights>(c) 2006 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4270-750eb684d7df0e20324db3ee124ded17b8bb06efe8e79498ab62276c374356f03</citedby><cites>FETCH-LOGICAL-c4270-750eb684d7df0e20324db3ee124ded17b8bb06efe8e79498ab62276c374356f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmed.20080$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmed.20080$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16788980$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brancale, Andrea</creatorcontrib><creatorcontrib>Silvestri, Romano</creatorcontrib><title>Indole, a core nucleus for potent inhibitors of tubulin polymerization</title><title>Medicinal research reviews</title><addtitle>Med. Res. Rev</addtitle><description>Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi‐synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti‐tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure–activity relationship aspects of 3‐formyl‐2‐phenylindoles, heterocombretastatins, diarylindoles, 2‐aroylindoles, D‐24851, 2‐aryl‐3‐aroylindoles, 3‐aroyl‐ and 1‐aroylindoles, and arylthioindoles are discussed. © 2006 Wiley Periodicals, Inc. Med Res Rev</description><subject>anti-mitotic agents</subject><subject>anti-tumor drugs</subject><subject>Antimitotic Agents - chemistry</subject><subject>Antimitotic Agents - pharmacology</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biochemistry - methods</subject><subject>Drug Design</subject><subject>Humans</subject><subject>indoles</subject><subject>Indoles - chemistry</subject><subject>Nerve Tissue Proteins - chemistry</subject><subject>Nerve Tissue Proteins - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>tubulin</subject><subject>Tubulin - drug effects</subject><subject>Tubulin - metabolism</subject><subject>Tubulin Modulators</subject><issn>0198-6325</issn><issn>1098-1128</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOwzAQRS0EgvJY8AMoKyQkQsd2YjtL1JaXeAgBYmnFyUQY0rjYiaB8PYGW7ljNaObcuziE7FM4oQBsOMXyhAEoWCMDCpmKKWVqnQyA9rvgLN0i2yG8AlCaUr5JtqiQSmUKBuTssildjcdRHhXOY9R0RY1diCrno5lrsWkj27xYY1vnQ-SqqO1MV9umf9bzKXr7lbfWNbtko8rrgHvLuUOeziaPo4v4-u78cnR6HRcJkxDLFNAIlZSyrAAZcJaUhiPSfmJJpVHGgMAKFcosyVRuBGNSFFwmPBUV8B1yuOideffeYWj11IYC6zpv0HVBC5WJjPGkB48WYOFdCB4rPfN2mvu5pqB_pOlemv6V1rMHy9LO_FxX5NJSDwwXwIetcf5_k76ZjP8q40XChhY_V4ncv2khuUz18-25fhhf3V-BfNaSfwPSfYUJ</recordid><startdate>200703</startdate><enddate>200703</enddate><creator>Brancale, Andrea</creator><creator>Silvestri, Romano</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200703</creationdate><title>Indole, a core nucleus for potent inhibitors of tubulin polymerization</title><author>Brancale, Andrea ; Silvestri, Romano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4270-750eb684d7df0e20324db3ee124ded17b8bb06efe8e79498ab62276c374356f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>anti-mitotic agents</topic><topic>anti-tumor drugs</topic><topic>Antimitotic Agents - chemistry</topic><topic>Antimitotic Agents - pharmacology</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biochemistry - methods</topic><topic>Drug Design</topic><topic>Humans</topic><topic>indoles</topic><topic>Indoles - chemistry</topic><topic>Nerve Tissue Proteins - chemistry</topic><topic>Nerve Tissue Proteins - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>tubulin</topic><topic>Tubulin - drug effects</topic><topic>Tubulin - metabolism</topic><topic>Tubulin Modulators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brancale, Andrea</creatorcontrib><creatorcontrib>Silvestri, Romano</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medicinal research reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brancale, Andrea</au><au>Silvestri, Romano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Indole, a core nucleus for potent inhibitors of tubulin polymerization</atitle><jtitle>Medicinal research reviews</jtitle><addtitle>Med. Res. Rev</addtitle><date>2007-03</date><risdate>2007</risdate><volume>27</volume><issue>2</issue><spage>209</spage><epage>238</epage><pages>209-238</pages><issn>0198-6325</issn><eissn>1098-1128</eissn><abstract>Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi‐synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti‐tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure–activity relationship aspects of 3‐formyl‐2‐phenylindoles, heterocombretastatins, diarylindoles, 2‐aroylindoles, D‐24851, 2‐aryl‐3‐aroylindoles, 3‐aroyl‐ and 1‐aroylindoles, and arylthioindoles are discussed. © 2006 Wiley Periodicals, Inc. Med Res Rev</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16788980</pmid><doi>10.1002/med.20080</doi><tpages>30</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0198-6325
ispartof Medicinal research reviews, 2007-03, Vol.27 (2), p.209-238
issn 0198-6325
1098-1128
language eng
recordid cdi_proquest_miscellaneous_68969234
source MEDLINE; Wiley Online Library All Journals
subjects anti-mitotic agents
anti-tumor drugs
Antimitotic Agents - chemistry
Antimitotic Agents - pharmacology
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Biochemistry - methods
Drug Design
Humans
indoles
Indoles - chemistry
Nerve Tissue Proteins - chemistry
Nerve Tissue Proteins - pharmacology
Structure-Activity Relationship
tubulin
Tubulin - drug effects
Tubulin - metabolism
Tubulin Modulators
title Indole, a core nucleus for potent inhibitors of tubulin polymerization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A35%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Indole,%20a%20core%20nucleus%20for%20potent%20inhibitors%20of%20tubulin%20polymerization&rft.jtitle=Medicinal%20research%20reviews&rft.au=Brancale,%20Andrea&rft.date=2007-03&rft.volume=27&rft.issue=2&rft.spage=209&rft.epage=238&rft.pages=209-238&rft.issn=0198-6325&rft.eissn=1098-1128&rft_id=info:doi/10.1002/med.20080&rft_dat=%3Cproquest_cross%3E68969234%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68969234&rft_id=info:pmid/16788980&rfr_iscdi=true